Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Burger

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer Immunology Research|April 30, 2014
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approachesGilson S Baia, Otavia L Caballero, Janelle S Y Ho, et al.
Neurosurgery|August 17, 2002
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustineRobert G Selker, William R Shapiro, Peter Burger, et al.
JAMA Oncology|July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology GroupSarah E S Leary, Roger J Packer, Yimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumorSusan N Chi, Mary Ann Zimmerman, Xiaopan Yao, et al.
Neuro-Oncology Advances|December 8, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma WorkshopMarta Penas-Prado, Jing Wu, Daniel P Cahill, et al.
Blood|October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieuYu-Tzu Tai, Myles Dillon, Weihua Song, et al.
Brain Pathology (Zurich, Switzerland)|July 4, 2014
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and gradingDavid N Louis, Arie Perry, Peter Burger, et al.
Oncotarget|August 8, 2012
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasYuchen Jiao, Patrick J Killela, Zachary J Reitman, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Immunology Research|April 30, 2014
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approachesGilson S Baia, Otavia L Caballero, Janelle S Y Ho, et al.
Neurosurgery|August 17, 2002
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustineRobert G Selker, William R Shapiro, Peter Burger, et al.
JAMA Oncology|July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology GroupSarah E S Leary, Roger J Packer, Yimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumorSusan N Chi, Mary Ann Zimmerman, Xiaopan Yao, et al.
Neuro-Oncology Advances|December 8, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma WorkshopMarta Penas-Prado, Jing Wu, Daniel P Cahill, et al.
Blood|October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieuYu-Tzu Tai, Myles Dillon, Weihua Song, et al.
Brain Pathology (Zurich, Switzerland)|July 4, 2014
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and gradingDavid N Louis, Arie Perry, Peter Burger, et al.
Oncotarget|August 8, 2012
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasYuchen Jiao, Patrick J Killela, Zachary J Reitman, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Pageof 7